Cargando…

Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol

INTRODUCTION: Atrial fibrillation (AF) affects >6% of people aged 65 years or older. Left undetected and untreated, patients may develop significant cardiovascular complications and have a fivefold increased risk of suffering a stroke. For 40% of all sufferers, AF can be asymptomatic. Every year...

Descripción completa

Detalles Bibliográficos
Autores principales: Veale, Emma L, Stewart, Adrian J, Mathie, Alistair, Lall, Satvinder K, Rees-Roberts, Melanie, Savickas, Vilius, Bhamra, Sukvinder K, Corlett, Sarah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857694/
https://www.ncbi.nlm.nih.gov/pubmed/29540425
http://dx.doi.org/10.1136/bmjopen-2017-021121
_version_ 1783307516716777472
author Veale, Emma L
Stewart, Adrian J
Mathie, Alistair
Lall, Satvinder K
Rees-Roberts, Melanie
Savickas, Vilius
Bhamra, Sukvinder K
Corlett, Sarah A
author_facet Veale, Emma L
Stewart, Adrian J
Mathie, Alistair
Lall, Satvinder K
Rees-Roberts, Melanie
Savickas, Vilius
Bhamra, Sukvinder K
Corlett, Sarah A
author_sort Veale, Emma L
collection PubMed
description INTRODUCTION: Atrial fibrillation (AF) affects >6% of people aged 65 years or older. Left undetected and untreated, patients may develop significant cardiovascular complications and have a fivefold increased risk of suffering a stroke. For 40% of all sufferers, AF can be asymptomatic. Every year in the UK, £2.2 billion is spent on AF-related strokes, so there is an urgent need to improve early detection of AF. This study aims to determine the feasibility of using trained clinical pharmacists based in general practices, to screen for AF, using pulse palpation and a single-lead ECG device on participants aged 65 years or older, attending influenza vaccination clinics. METHODS AND ANALYSIS: Seven clinical pharmacists will be trained by a cardiologist to pulse palpate and record single-lead ECGs using the AliveCor Kardia Mobile device. Quantitative analysis will assess the accuracy and ability of the clinical pharmacist to identify pulse irregularities using pulse palpation and to record and interpret a single-lead ECG. The level of agreement of pulse irregularities detected by pulse palpation will be compared with those detected by the single-lead ECG device, as will the level of agreement between the cardiologist and the device’s interpretation of the ECG. The proportion of people identified with AF (confirmed by the cardiologist) will be determined. Additional demographic data will be obtained from all participants through a questionnaire. Qualitative data will be captured from the participants, from the clinical pharmacists and from the general practitioners and practice staff to determine their views on this method of AF screening. We aim to recruit 600 participants across general practices within Kent. ETHICS AND DISSEMINATION: This protocol was approved by the London–Riverside Research Ethics committee. The findings of this study will be disseminated through forums including, but not limited to, peer-reviewed journals, national and international conferences.
format Online
Article
Text
id pubmed-5857694
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58576942018-03-20 Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol Veale, Emma L Stewart, Adrian J Mathie, Alistair Lall, Satvinder K Rees-Roberts, Melanie Savickas, Vilius Bhamra, Sukvinder K Corlett, Sarah A BMJ Open Health Services Research INTRODUCTION: Atrial fibrillation (AF) affects >6% of people aged 65 years or older. Left undetected and untreated, patients may develop significant cardiovascular complications and have a fivefold increased risk of suffering a stroke. For 40% of all sufferers, AF can be asymptomatic. Every year in the UK, £2.2 billion is spent on AF-related strokes, so there is an urgent need to improve early detection of AF. This study aims to determine the feasibility of using trained clinical pharmacists based in general practices, to screen for AF, using pulse palpation and a single-lead ECG device on participants aged 65 years or older, attending influenza vaccination clinics. METHODS AND ANALYSIS: Seven clinical pharmacists will be trained by a cardiologist to pulse palpate and record single-lead ECGs using the AliveCor Kardia Mobile device. Quantitative analysis will assess the accuracy and ability of the clinical pharmacist to identify pulse irregularities using pulse palpation and to record and interpret a single-lead ECG. The level of agreement of pulse irregularities detected by pulse palpation will be compared with those detected by the single-lead ECG device, as will the level of agreement between the cardiologist and the device’s interpretation of the ECG. The proportion of people identified with AF (confirmed by the cardiologist) will be determined. Additional demographic data will be obtained from all participants through a questionnaire. Qualitative data will be captured from the participants, from the clinical pharmacists and from the general practitioners and practice staff to determine their views on this method of AF screening. We aim to recruit 600 participants across general practices within Kent. ETHICS AND DISSEMINATION: This protocol was approved by the London–Riverside Research Ethics committee. The findings of this study will be disseminated through forums including, but not limited to, peer-reviewed journals, national and international conferences. BMJ Publishing Group 2018-03-14 /pmc/articles/PMC5857694/ /pubmed/29540425 http://dx.doi.org/10.1136/bmjopen-2017-021121 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Health Services Research
Veale, Emma L
Stewart, Adrian J
Mathie, Alistair
Lall, Satvinder K
Rees-Roberts, Melanie
Savickas, Vilius
Bhamra, Sukvinder K
Corlett, Sarah A
Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol
title Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol
title_full Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol
title_fullStr Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol
title_full_unstemmed Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol
title_short Pharmacists detecting atrial fibrillation (PDAF) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol
title_sort pharmacists detecting atrial fibrillation (pdaf) in primary care during the influenza vaccination season: a multisite, cross-sectional screening protocol
topic Health Services Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857694/
https://www.ncbi.nlm.nih.gov/pubmed/29540425
http://dx.doi.org/10.1136/bmjopen-2017-021121
work_keys_str_mv AT vealeemmal pharmacistsdetectingatrialfibrillationpdafinprimarycareduringtheinfluenzavaccinationseasonamultisitecrosssectionalscreeningprotocol
AT stewartadrianj pharmacistsdetectingatrialfibrillationpdafinprimarycareduringtheinfluenzavaccinationseasonamultisitecrosssectionalscreeningprotocol
AT mathiealistair pharmacistsdetectingatrialfibrillationpdafinprimarycareduringtheinfluenzavaccinationseasonamultisitecrosssectionalscreeningprotocol
AT lallsatvinderk pharmacistsdetectingatrialfibrillationpdafinprimarycareduringtheinfluenzavaccinationseasonamultisitecrosssectionalscreeningprotocol
AT reesrobertsmelanie pharmacistsdetectingatrialfibrillationpdafinprimarycareduringtheinfluenzavaccinationseasonamultisitecrosssectionalscreeningprotocol
AT savickasvilius pharmacistsdetectingatrialfibrillationpdafinprimarycareduringtheinfluenzavaccinationseasonamultisitecrosssectionalscreeningprotocol
AT bhamrasukvinderk pharmacistsdetectingatrialfibrillationpdafinprimarycareduringtheinfluenzavaccinationseasonamultisitecrosssectionalscreeningprotocol
AT corlettsaraha pharmacistsdetectingatrialfibrillationpdafinprimarycareduringtheinfluenzavaccinationseasonamultisitecrosssectionalscreeningprotocol